PacBio Proof-of-Concept Paper Sheds Additional Light on SMRT Technology | GenomeWeb
An article published two weeks ago by Pacific Biosciences disclosed details of its sequencing technology and showed that the company can collect sequence data from single DNA polymerase enzymes.
The paper serves as a proof of concept for the technology and is “really a full disclosure of how the system works,” Steve Turner, PacBio’s chief technology officer, told In Sequence two weeks ago.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.